Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Munoz-Lucas, C. Wagner-Struwing, J. Jareno-Esteban, J. de Miguel-Diez, B. Carrillo-Aranda, C. Gutierrez-Ortega, C. Civera-Tejuca, L. Callol-Sanchez (Madrid, Spain). Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD. Eur Respir J 2013; 42: Suppl. 57, 2892

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Detection of lung cancer using expired breath analysis by ion mobility spectrometry Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 The research on early detection of lung cancer with exhaled volatile organic compounds Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Breath collection related factors may influence electronic nose ability to detect lung cancer Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Volatile organic compounds in COPD: Is hexanal an inflammation biomarker? Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010